ICN Pharmaceuticals Inc. to test AIDS treatment
- Share via
The Costa Mesa drug research company said Thursday that its ribavirin drug will be tested on 21 AIDS victims at New York Hospital. The drug is used in fighting the virus believed to cause acquired immune deficiency syndrome. The company said it also is awaiting U.S. Food and Drug Administration approval for use of ribavirin in treating respiratory syncytial virus, a disease affecting about 800,000 infants, children and elderly annually in the United States.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
